{"id":524074,"date":"2026-07-03T23:32:09","date_gmt":"2026-07-03T23:32:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/524074\/"},"modified":"2026-07-03T23:32:09","modified_gmt":"2026-07-03T23:32:09","slug":"q1-earnings-roundup-mettler-toledo-nysemtd-and-the-rest-of-the-research-tools-consumables-segment","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/524074\/","title":{"rendered":"Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables Segment"},"content":{"rendered":"

\"MTD<\/a> Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables Segment <\/p>\n

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how research tools & consumables stocks fared in Q1, starting with Mettler-Toledo (NYSE:MTD). <\/p>\n

The life sciences subsector specializing in research tools and consumables enables scientific discoveries across academia, biotechnology, and pharmaceuticals. These firms supply a wide range of essential laboratory products, ensuring a recurring revenue stream through repeat purchases and replenishment. Their business models benefit from strong customer loyalty, a diversified product portfolio, and exposure to both the research and clinical markets. However, challenges include high R&D investment to maintain technological leadership, pricing pressures from budget-conscious institutions, and vulnerability to fluctuations in research funding cycles. Looking ahead, this subsector stands to benefit from tailwinds such as growing demand for tools supporting emerging fields like synthetic biology and personalized medicine. There is also a rise in automation and AI-driven solutions in laboratories that could create new opportunities to sell tools and consumables. Nevertheless, headwinds exist. These companies tend to be at the mercy of supply chain disruptions and sensitivity to macroeconomic conditions that impact funding for research initiatives. <\/p>\n

The 10 research tools & consumables stocks we track reported a mixed Q1. As a group, revenues beat analysts’ consensus estimates by 1.3% while next quarter’s revenue guidance was 2% above. <\/p>\n

Luckily, research tools & consumables stocks have performed well with share prices up 20.8% on average since the latest earnings results. <\/p>\n

Mettler-Toledo (NYSE:MTD) <\/p>\n

With roots dating back to the precision balance innovations of Swiss engineer Erhard Mettler, Mettler-Toledo (NYSE:MTD) manufactures precision weighing instruments, analytical equipment, and product inspection systems used in laboratories, industrial settings, and food retail. <\/p>\n

Mettler-Toledo reported revenues of $947.1 million, up 7.2% year on year. This print exceeded analysts’ expectations by 0.6%. Despite the top-line beat, it was still a mixed quarter for the company with a beat of analysts’ EPS estimates. <\/p>\n

\"Mettler-Toledo<\/a> <\/p>\n

The market was likely pricing in the results, and the stock is flat since reporting. It currently trades at $1,308. <\/p>\n

Read our full report on Mettler-Toledo here, it’s free<\/a>. <\/p>\n

Best Q1: Waters Corporation (NYSE:WAT) <\/p>\n

Founded in 1958 and pioneering innovations in laboratory analysis for over six decades, Waters (NYSE:WAT) develops and manufactures analytical instruments, software, and consumables for liquid chromatography, mass spectrometry, and thermal analysis used in scientific research and quality testing. <\/p>\n

Story Continues <\/p>\n

Waters Corporation reported revenues of $1.27 billion, up 91.5% year on year, outperforming analysts’ expectations by 4.5%. The business had a very strong quarter with an impressive beat of analysts’ organic revenue estimates and revenue guidance for next quarter exceeding analysts’ expectations. <\/p>\n

\"Waters<\/a> <\/p>\n

Waters Corporation scored the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth among its peers. The market seems happy with the results as the stock is up 25.6% since reporting. It currently trades at $379.24. <\/p>\n

Is now the time to buy Waters Corporation? Access our full analysis of the earnings results here, it’s free<\/a>. <\/p>\n

Revvity (NYSE:RVTY) <\/p>\n

Formerly known as PerkinElmer until its rebranding in 2023, Revvity (NYSE:RVTY) provides health science technologies and services that support the complete workflow from discovery to development and diagnosis to cure. <\/p>\n

Revvity reported revenues of $686.9 million, up 9.3% year on year, falling short of analysts’ expectations by 2.6%. It was a softer quarter as it posted full-year revenue guidance missing analysts’ expectations and a significant miss of analysts’ full-year EPS guidance estimates. <\/p>\n

Revvity delivered the weakest performance against analyst estimates and weakest full-year guidance update in the group. Interestingly, the stock is up 31.4% since the results and currently trades at $113.70. <\/p>\n

Read our full analysis of Revvity’s results here.<\/a> <\/p>\n

Sotera Health Company (NASDAQ:SHC) <\/p>\n

With a critical role in ensuring the safety of millions of patients worldwide, Sotera Health (NASDAQGS:SHC) provides sterilization services, lab testing, and advisory services to ensure medical devices, pharmaceuticals, and food products are safe for use. <\/p>\n

Sotera Health Company reported revenues of $280 million, up 10% year on year. This print surpassed analysts’ expectations by 3.6%. It was a strong quarter as it also logged an impressive beat of analysts’ organic revenue estimates and EPS in line with analysts’ estimates. <\/p>\n

The stock is up 16.5% since reporting and currently trades at $17.94. <\/p>\n

Read our full, actionable report on Sotera Health Company here, it’s free.<\/a> <\/p>\n

Bruker (NASDAQ:BRKR) <\/p>\n

With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ:BRKR) develops and manufactures high-performance scientific instruments that enable researchers and industrial analysts to explore materials at microscopic, molecular, and cellular levels. <\/p>\n

Bruker reported revenues of $823.4 million, up 2.7% year on year. This result topped analysts’ expectations by 3.4%. Overall, it was a very strong quarter as it also put up a beat of analysts’ EPS and organic revenue estimates. <\/p>\n

The stock is up 62.4% since reporting and currently trades at $61.74. <\/p>\n

Read our full, actionable report on Bruker here, it’s free.<\/a> <\/p>\n

Market Update <\/p>\n

Late in 2025 into early 2026, there was hand-wringing around artificial intelligence. For software companies, the fear was that AI would erode pricing power and compress margins as new tools made it easier to replicate what once required expensive enterprise platforms. Crypto investors had their own version of the same anxiety: if AI agents could trade, allocate capital, and manage wallets autonomously, what exactly was the long-term value of today’s crypto infrastructure? <\/p>\n

These concerns triggered a noticeable rotation away from these sectors and into safer havens. But markets rarely dwell on one narrative for long. Spring 2026 came, and the focus shifted abruptly from technological disruption to geopolitical risk. The US’ conflict with Iran became the dominant driver of market psychology, and when geopolitics takes center stage, the script changes quickly. Investors stop debating growth rates and start worrying about oil supply, inflation, and global stability. <\/p>\n

Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks<\/a> and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. <\/p>\n","protected":false},"excerpt":{"rendered":"Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables Segment The end of…\n","protected":false},"author":2,"featured_media":524075,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[114,230569,108341,69852,11881,85,46,239728,27247,76504,230566],"class_list":["post-524074","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-consumables","tag-earnings-results","tag-eps-estimates","tag-expectations","tag-il","tag-israel","tag-mettler-toledo","tag-quarter","tag-revenue-guidance","tag-waters-corporation"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/524074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=524074"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/524074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/524075"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=524074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=524074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=524074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}